News Hub | News Direct

All Industries


Article thumbnail News Release

Kadena SpireKey Integrates with WebAuthn to Provide Seamless Web3 Interactions

Kadena

Introducing Kadena SpireKey, a human-friendly and secure way to seamlessly interact with any application by removing complex signing processes. Kadena Spirekey “Unlike complex Web3 wallets today where you have to remember every wallet you’ve ever created, Kadena’s SpireKey uses WebAuthn, a technology that has been developed by Google and Apple over the last 20 years, to help anyone securely digital assets directly on your phone or computer. It’s as easy as receiving a prompt on your mobile device and providing a fingerprint as a signature. Even that uncle who asks you about crypto every family holiday dinner can do it. With Kadena, we've made using applications accessible to everyone, no matter if you’re an experienced "degen" or using blockchain for the first time,” said Kadena CMO, Mike Herron. SpireKey creates a seamless interaction between humans and technology, providing a Web2 experience with Web3 innovation. With SpireKey, users can sign transactions and Web3 applications, just like how it works on Apple Pay or Google Pay. However, it can be done directly on the user's device without opening multiple windows or copying and pasting keypairs, which eliminates potential vulnerabilities seen in traditional wallets. Added Security with Built-in Multi-sig “Kadena's built-in multi-sig signing enables an additional layer of security for SpireKey that only we can provide through our original language, Pact. With multi-sig, SpireKey allows for multiple signatures to be required for certain transaction types. For example, if you want to send over $10,000, you can set up parameters to require signatures from three different devices – your phone, laptop, and cold storage wallet. The multi-sig feature reduces the risk of compromised accounts because a bad actor would need access to three devices. It mitigates the risk of another attack vector, and adds to the overall security,” said Stuart Popejoy, Kadena Co-Founder and CEO. SpireKey displays how Kadena thinks about the level of usability that Web3 technology should be at. At its core, SpireKey connects humans to interact with the blockchain, and with one another. SpireKey believes that showing working examples will inspire all humans alike to see how Spirekey can impact the rest of the world beyond Web3. About Kadena Kadena is a blockchain technology protocol that was founded in 2017 by Stuart Popejoy and Will Martino. Kadena is the industry’s only scalable Layer-1 Proof of Work (PoW) blockchain. This scalability enables Kadena to deliver infrastructure-grade performance for any blockchain project. Along with Kadena own smart contract language Pact, Kadena’s platform provides the world with the tools and environment to turn ideas and ambitions into reality. Founded by Stuart Popejoy and William Martino, who created JP Morgan’s first blockchain and led the SEC’s Crypto Committee, Kadena aims to allow for true blockchain mass adoption. For more information, users can follow Kadena's: Twitter | Telegram | Discord | YouTube Contact Details Kadena Kadena Press press@kadena.io

February 16, 2024 10:00 AM Eastern Standard Time

Video Image
Article thumbnail News Release

Rootz LTD Successfully Defends Trademarks and Domains Against Blackhat Affiliate Attacks

impulsQ

Ensuring good corporate governance involves maintaining accessible records, such as trademark registration dates and proof of domain name purchases associated with the trademark. A case is Rootz LTD, the parent platform of numerous online casinos. Rootz recently demonstrated securing the various versions of its brand domain name, including the acquisition of related domains such as Wildzcasino.com. This strategic move aimed to direct customers searching for Wildz.com under the term "casino" to the correct address, safeguarding the company's brand and avoiding confusion. A domain name holds significant importance for any business as it represents the unique name associated with a physical IP address online. Whether it's found after the "@" in email addresses or after "www" in web addresses, it plays a vital role. Acquiring a domain name involves visiting a domain host or registrar, searching for an available name, and paying a small annual fee to become the rightful owner. Rootz LTD's Battle Against Blackhat Marketing Tactics Keeping accessible records, such as trademark registration dates and proof of domain name purchases, is a key aspect of good corporate governance. A prime example of this is Rootz LTD, a parent platform to several online casinos. Rootz took proactive measures to secure different versions of its brand domain name, including acquiring related domains like Wildzcasino.com. This strategic move aimed to direct customers searching for Wildz.com under the term "casino" to the correct address, safeguarding the brand and minimizing confusion. However, amidst efforts to protect domain names, companies face threats from unscrupulous competitors who employ deceptive marketing practices known as "Blackhat Marketing." In December 2020, Rootz brands became targets for blackhat affiliate marketing companies due to significant search volumes in Germany. These malicious actors launched Distributed Denial of Service (DDoS) attacks and attempted to advertise a competitor using nearly identical names. Fortunately, Rootz diligently monitored site traffic and managed the attacks, ensuring minimal impact on their brand and customers. Adjudication Panel Validates Rootz's Domain Name Ownership Right To address disputes related to domain name ownership, the World Intellectual Property Organization (WIPO) provides the Uniform Domain Name Dispute Resolution Policy (UDRP Policy). This legal framework assists in resolving conflicts between domain name registrants and third parties over the abusive registration and usage of a domain name. Recently, Rootz faced a dispute over confusingly similar names and ownership rights, resulting in the adjudication panel ruling in their favor and confirming their right to ownership of the disputed domain name. Protecting a brand and maintaining a positive reputation is vital for avoiding such attacks and ensuring customer loyalty. By maintaining thorough records and ownership proof, companies can mitigate the impact of these attacks and save valuable time that would otherwise be spent in lengthy legal battles. The assurance of ownership allows companies to emerge victorious and maintain a positive reputation in the market. About Rootz LTD Founded by a team of seasoned iGaming professionals, Rootz prioritizes innovative and efficient programming, visually stunning graphics, and immersive content, resulting in a gaming platform that provides an unrivaled online gaming experience. Rootz is an iGaming company based in Malta, catering to Scandinavian, German, Canadian, and various other European and international markets. Established in 2018 by a team of gaming experts, Rootz has emerged as the parent platform for five superior online casinos: Wildz, Wheelz, Spinz, Caxino, and Chipz. These platforms offer entertainment across multiple global markets. The company distinguishes itself with a philosophy centered on quality rather than quantity. While other iGaming companies resort to an abundance of personnel to overcome obstacles, Rootz embraces automation to eliminate redundant processes. By prioritizing efficiency and staying focused on its mission, Rootz approaches iGaming with skilled professionals, cutting-edge systems and programming, and a keen eye for future trends and challenges. Contact Details Rootz LTD Mikael Jukarainen info@rootz.com

February 16, 2024 09:34 AM Eastern Standard Time

Image
Article thumbnail News Release

Announcing the 2024 Global DEI Conference: A Catalyst for Sustainable Change

1BusinessWorld

In an era marked by rapid global changes and increasing recognition of the value of diversity, equity, and inclusion (DEI), the 2024 Global DEI Conference emerges as a pivotal event, scheduled from May 28 to May 30, 2024. With a compelling theme, " Fostering Equity for Success," this year’s conference innovates through a hybrid model, blending the immediacy of in-person engagement with the broad accessibility of digital platforms. This format promises to democratize participation and foster a truly global dialogue on DEI. As businesses and societies grapple with complex challenges, the imperative for integrating DEI principles into the fabric of our organizations and communities has never been more pronounced. The Global DEI Conference 2024 is poised to serve as a beacon for thought leadership, offering a forward-thinking agenda that addresses the multifaceted aspects of DEI. Strategic Insights and Collaborative Solutions This conference is designed for those who lead, those who innovate, and those who inspire change within their organizations and communities. It offers a rare convergence of global experts, thought leaders, and practitioners across various sectors, providing a rich tapestry of perspectives on DEI. Participants will gain: - Insights from cutting-edge research and case studies, illuminating the path to embedding DEI into strategic objectives. - Strategies for navigating the complexities of organizational change, with a focus on achieving tangible DEI outcomes. - Opportunities for high-level networking, fostering collaborations that transcend geographical and sectoral boundaries. - Interactive experiences designed to challenge, educate, and inspire, moving beyond discourse to actionable change. Why Participation Is Imperative The 2024 Global DEI Conference is not merely an event but a strategic inflection point for participants to recalibrate their approach to DEI. It offers a platform to influence the global DEI agenda, share innovative practices, and catalyze collective action towards more equitable organizations and societies. This conference is essential for: - Leaders seeking to cultivate an inclusive culture that drives innovation and business success. - Practitioners looking to advance their DEI strategies with evidence-based practices and global insights. - Individuals committed to personal growth and contributing to societal change through the lens of DEI. Join Us on This Transformative Journey We invite you to mark your calendars and register for the 2024 Global DEI Conference. Your participation is not just an investment in your professional development but a step towards contributing to a more equitable and inclusive future. For registration and further information, please visit All news and content distribution in partnership with News Direct. About Ludo: Ludo provides tech for inclusion. The foundation of Ludo is a digital solution to drive wellbeing and inclusion in the workplace. Ludo provides resource for all employees, offers HR consulting, Coaching, Workshops, Learning & Development and Speakers. We work with businesses to provide a full wrap around service to drive a successful culture of wellbeing & inclusion. Our digital platform provides full wrap around support through Maternity, instant information on Menopause, Fertility and Health, including Mental Health. Ludo About 1BusinessWorld: 1BusinessWorld is a global business ecosystem, network and marketplace that provides entrepreneurs, business owners and professionals with the information, tools, resources and connectivity needed to succeed throughout their company’s growth journey, toward a better business world. Our vision is based on the reality that we live, work and do business in one global interconnected business environment, and hence our motto: “One World, One Business World”. Our mission is to encourage and support global communication and collaboration among entrepreneurs, professionals, and businesses. 1BusinessWorld Contact Details Media Enquiries +1 212-220-6677 info@1businessworld.com Company Website https://1businessworld.com

February 16, 2024 08:57 AM Eastern Standard Time

Image
Article thumbnail News Release

Gates Ventures, Mayo Clinic Back Tiny Robot Created By $400M Apple Face ID Inventors To Treat Brain Disease

OurCrowd

By Matthew Kalman PrimeSense, the previous company founded by Michael Shpigelmacher, Aviad Maizels and Alex Shpunt, was acquired in 2013 by Apple (NASDAQ: AAPL) for around $400 million. It was a world leader in 3D sensors that helped power the Microsoft (NASDAQ: MSFT) Kinect for Xbox 360 and provided the technology behind Apple’s Face ID. Bionaut Labs, the medical startup founded by the trio, is on a very different journey – into the deepest recesses of the human brain. But the company is already making waves. This month, Bill Gates’ Gates Ventures joined its early funders, extending investment to $70 million from a blue-chip roster including the Mayo Clinic, Khosla Ventures, Upfront Ventures and OurCrowd, Fortune magazine reported. The company’s Bionaut, a tiny micro-robot smaller than a grain of rice, is guided through a patient’s central nervous system into a targeted spot in the brain where it can perform minor surgery, deliver therapeutic drugs or return with tissue for a biopsy. Not since Raquel Welch was shrunk and inserted into a patient’s bloodstream in the 1966 movie “Fantastic Voyage” have doctors come so close to targeting life-saving medication so precisely to reach the inaccessible recesses of the human body. The company is testing its technology at a Mayo Clinic facility and is poised to begin clinical trials with five top-tier U.S. medical centers as it applies for FDA approval. Investors can still join the Bionaut Labs funding round via the OurCrowd investment platform. Shpigelmacher, CEO of Bionaut Labs, says he realized that treatments for disease occurring at a specific point in the body – especially the brain – were not being accurately targeted. He likens the effect of existing treatments to “carpet bombing a patient’s body with drugs,” creating “widespread undesired side effects or damage to surrounding tissue and organs.” “There we were, flooding the whole body. It was like having one dirty dish in the sink and bringing out a fire hose that floods the whole house just to wash that single dish,” he says. The Bionaut, guided by a physician using a powerful magnet, can release a payload of targeted therapy directly into a tumor or any other localized target – even deep inside the brain – and head for home. “Surgeries to get to the brain tend to be relatively aggressive and fairly in depth and carry a lot of risks associated with them and a lot of recovery time,” says Dr Bill Loudon, VP of Neuroscience at Bionaut Labs. The blood-brain barrier creates “very significant problems to try to get drugs to where we want it to go. On the surgical side it’s hard to get into the brain and on the drug side it’s hard to get into the tissues.” “The Bionaut has specific advantages that circumvent these problems. It truly represents a whole new level,” Dr Loudon says. The company has developed several micro-robot prototypes, each designed for a different purpose. There is a capsule-shaped Bionaut designed to move through fluid, a corkscrew-shaped Bionaut designed to burrow through tissue and a sharp-pointed Bionaut that can perform microsurgery by slicing through the kind of cyst in the brain that causes hydrocephalus, or Dandy-Walker Syndrome. A Bionaut can carry a therapeutic payload and deliver it directly to the targeted area, which avoids flooding the entire central nervous system. Instead of drilling through several centimeters of brain tissue, the Bionaut can be guided through internal fluids to within millimeters of its target. “We minimize tissue penetration, doing it only for the safest and shortest distance possible. It opens a completely new way of treating brain diseases,” Shpigelmacher says. Each tiny Bionaut contains a powerful magnet that allows it to be remotely controlled from outside the body. The patient has an MRI or CT scan, which the physician uses to plan the safest route to the affected area and then loads the route onto a computer. The patient is sedated and the Bionaut is injected into the central nervous system at the entry point worked out in advance. Then, the computer takes over, guiding the probe to its destination while causing the least possible damage to surrounding tissue as the physician monitors its progress via X-ray. $130 Billion Market “The market for brain and CNS therapeutics is massive – over $130 billion today and estimated to grow to over $200 billion. Most of it is drugs,” Shpigelmacher says. Pharma giants are targeting a wide range of neuro-degenerative conditions including Parkinson’s, Huntington’s, Alzheimer’s, epilepsy, glioblastoma and many more, but they all face the challenge of getting the drugs to the point where they are needed inside the brain. “The problem is, even if you have the best drug how are you going to get it to the target?” Shpigelmacher says. “This is where Bionaut steps in. Bionaut does not aim to replace these drugs or replace these payloads. It aims to provide a way for the drug manufacturer to get their payload to the target. So even if we just focus on neuro-degeneration, brain cancer and epilepsy – that alone is over a $70 billion market today.” “We’re already in discussions with the FDA to take this to the clinic next year. The idea is that by the end of 2024 we will have early human data for the device, and in 2025 we will license it out for broader neurological indications,” Shpigelmacher says. The company hopes to emulate the success of other companies specializing in robotic surgery and the treatment of neurodegenerative diseases. Intuitive Surgical (NASDAQ: ISRG), a leader in surgical robotics, is worth more than $100 billion. Halozyme (NASDAQ: HALO), which partners with major pharma companies to reformulate drugs for precision use, earns millions of dollars each year and is valued at almost $5 billion. “When we started this research, many of the physicians we spoke to, specialists in cardiology, gastroenterology, ophthalmology and more, simply asked, ‘When can we sign up?’” Shpigelmacher says. For more information about joining Bionaut Labs’ extension round via the OurCrowd platform, click HERE. Featured photo courtesy of Bionaut Labs. OurCrowd was started in 2013, driven by the idea that the business of building startups grows bigger and better when the global ‘crowd’ gains access to VC-level investment opportunities.Today, OurCrowd is a global venture and alternative investing platform that empowers institutions and individuals to invest and engage in emerging companies. OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Lisa Graston lisa.graston@ourcrowd.com Company Website http://www.ourcrowd.com

February 16, 2024 08:35 AM Eastern Standard Time

Video Image
Article thumbnail News Release

Battery Mineral Resources Corp. Announces Third Closing of Previously Announced Offering of Unsecured Convertible Debentures

Battery Mineral Resources Corp.

Battery Mineral Resources Corp. ( TSXV: BMR ) ( OTCQB: BTRMF ) (“ Battery ” or “ BMR ” or the “ Company ”) is pleased to announce that it has closed a third, and final, tranche of the private placement (the “ Private Placement ”) of senior unsecured convertible debentures (the “ Debentures ”), which was previously announced on October 17, 2023, October 19, 2023, November 3, 2023, December 19, 2023 and February 2, 2024 (the “ Offering ”). Gross proceeds for the third tranche total US$1,000,000 (C$1,349,300). Together with the first tranche of the Offering, which closed on October 19, 2023 for gross proceeds of US$1,370,000 (C$1,871,557), and the second tranche of the Offering, which closed on November 3, 2023 for gross proceeds of US$1,915,000 (C$2,660,234), the Company raised an aggregate of US$4,285,000 (C$5,881,091) under the Offering. Weston Energy II LLC, an existing shareholder of the Company, participated in the third closing in the amount of US$1,000,000 (C$1,349,300). The proceeds from the Debentures will be applied towards working capital and the restart of copper concentrate production at its Punitaqui copper project in Chile (the “ Restart ”). Offering Terms (as previously disclosed) As previously announced, the Debentures will mature on September 30, 2026 (the “ Maturity Date ”) and will bear interest at 10% per annum, compounding annually on September 30 of each year, not in advance. Interest accrued from the date of issuance up to and including March 30, 2025, will be paid by way of issuance of common shares of the Company. Interest accrued following March 30, 2025, will be, at the option of the holder, paid either in cash or by way of issuance of common shares of the Company. The issuance of common shares as payment of interest will be at the then current market price of the Company’s common shares at the date the interest becomes payable and will be subject to the prior acceptance of the TSX Venture Exchange and applicable securities laws. The holder of a Debenture may, at their option, at any time from March 31, 2024, and prior to the close of business on the business day immediately preceding the Maturity Date, convert all, but not less than all, of the principal amount of such Debenture into common shares of the Company at the conversion price of US$0.22 per share (approximately C$0.30 per share). All Debentures issued in the Private Placement and in connection with the debt consolidation are subject to a four month hold period under applicable Canadian securities laws and under the policies of the TSX Venture Exchange. The Debenture issuances are subject to final approval by the TSX Venture Exchange. Exchange Rates All USD amounts for which CAD equivalent amounts are given in this news release were calculated at CAD/USD exchange rate of 1.3493, the exchange rate published by the Bank of Canada on February 15, 2024. MI 61-101 Matters Weston Energy LLC and Weston Energy II LLC are “related parties” to BMR pursuant to pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“ MI 61-101 “). Prior to giving effect to the transactions disclosed in this news release, Weston Energy LLC and Weston Energy II LLC and its affiliates owned or controlled (directly or indirectly) 107,578,740 BMR Common Shares on an undiluted basis and 175,201,710 BMR Common Shares assuming the conversion of the Company’s Debentures (representing approximately 60.60% of the outstanding BMR Common Shares on an undiluted basis, and approximately 65.66% of the outstanding BMR Common Shares assuming the conversion of the Company’s Debentures). Weston Energy II LLC’s participation in the Private Placement constitutes a “related party transaction” for the purposes of MI 6-101. The transaction is exempt from the formal valuation requirements of MI 61-101 as BMR is not listed on a specified market that would require compliance with such formal valuation requirements (as set forth in Section 5.5(b) of MI 61-101) and is further exempt from the minority shareholder approval requirements of MI 61-101 by virtue of Section 5.7(e) of MI 61-101 which provides that a related party transaction is exempt from the minority shareholder approval requirements if the issuer is in serious financial difficulty, the transaction is designed to improve the financial position of the company (among other criteria) and there is no other requirement to hold a meeting of shareholders to approve the transaction. Disclaimers The Debentures (including any issued in future closings) will be sold in a transaction exempt from registration under the Securities Act of 1933, as amended (the “ Securities Act ”) and will be sold only to persons reasonably believed to be accredited investors in the United States under Rule 506 under the Securities Act and outside the United States only to non-U.S. persons in accordance with Regulation S under the Securities Act. The Debentures and the shares of common stock issuable upon conversion of the Debentures, if any, have not been and will not be registered under the Securities Act, or any state securities laws, and unless so registered, may not be offered or sold in the United States except pursuant to an applicable exemption from such registration requirements of the Securities Act and applicable state securities laws. This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the Debentures or any shares of common stock potentially issuable upon conversion of the Debentures nor shall there be any sale of Debentures (or shares issuable upon conversion thereof) in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state. There can be no assurance that any future offerings of Debentures will be completed. About Battery Mineral Resources Corp. BMR is a battery minerals company providing shareholders exposure to the global mega-trend of electrification while being focused on growth through cash-flow, exploration, and acquisitions in favourable mining jurisdictions. BMR’s mission is the discovery, acquisition, and development of battery metals (namely cobalt, lithium, graphite, and copper), in North America, South America and South Korea and to become a premier and responsible supplier of battery minerals to the electrification marketplace. BMR is currently pursuing a near-term resumption of operations of the Punitaqui Mining Complex, a past copper-gold-silver producer, in the Coquimbo region of Chile. BMR is the largest mineral claim holder in the historic Gowganda Cobalt-Silver Camp in Ontario, Canada, and continues to pursue a focused program to build on the recently announced, +1-million-pound high-grade cobalt resource at McAra. In addition, Battery Mineral owns 100% of ESI Energy Services, Inc. (including ESI’s wholly owned USA operating subsidiary, Ozzie’s, Inc.), a profitable mainline pipeline and renewable energy equipment rental and sales company with operations in Alberta, Canada and Arizona, USA. Battery Mineral Resources is based in Canada and its shares are listed on the TSX Venture Exchange under the symbol “BMR” and on the OTCQB under the symbol “BTRMF”. Further information about BMR and its projects can be found on www.bmrcorp.com. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this press release. Forward Looking Statements This news release includes certain “forward-looking statements” under applicable securities laws. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements reflect the beliefs, opinions and projections of the Company on the date the statements are made and are based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies. Many factors, both known and unknown, could cause actual results, performance, or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements and the parties have made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation, the ability of the Company to obtain sufficient financing (including through the Private Placement) to complete exploration and development activities, the ability of the Company to close further tranches of the Private Placement, the completion, timing and size of the proposed Private Placement, the intended use of the proceeds of the Private Placement, risks related to share price and market conditions, the inherent risks involved in the mining, exploration and development of mineral properties, the ability of the Company to meet its anticipated development schedule, government regulation and fluctuating metal prices. Accordingly, readers should not place undue reliance on forward-looking statements. Battery undertakes no obligation to update publicly or otherwise revise any forward-looking statements contained herein, whether as a result of new information or future events or otherwise, except as may be required by law. For further information regarding the risks please refer to the risk factors discussed in Battery’s most recent Management Discussion and Analysis filed on SEDAR+. Contact Details Martin Kostuik, CEO +1 604-229-3830 info@bmrcorp.com Corporate Communications IBN (InvestorBrandNetwork) +1 310-299-1717 editor@investorbrandnetwork.com Company Website https://bmrcorp.com/

February 16, 2024 05:30 AM Pacific Standard Time

Article thumbnail News Release

Argentina Is On Its Way To Dollarization And Here's How Gaucho Group Holdings (NASDAQ: VINO) Is Set Up To Capitalize

Benzinga

By Faith Ashmore, Benzinga Earlier in November, Argentina elected right-wing libertarian Javiar Milei as president; he ran on the promise of economic shock therapy, which resonated with voters. One of his biggest action items was to adopt the U.S. dollar and leave Argentina’s peso behind. This solution is seen by Milei’s supporters as a way to reduce the country’s runaway inflation and minimize the government’s overspending. While there is criticism of this plan, certain factions of the country support it full-heartedly. Some Argentinians have already adopted the U.S. dollar for domestic transitions like Airbnb rentals and even wages. Individuals in the real estate market have been supportive, especially as property prices are on the rise and there was a 53.3% increase in property deeds signed in October compared to the previous year. For some of these investors, dollarization equates to increased profit. Argentina’s Gaucho Group Holdings Inc. (NASDAQ: VINO), which focuses on luxury industries and luxury real estate, seems well-positioned to be a leader in the space as Argentina’s economy rebounds. Gaucho Holdings has been investing in the Argentinian market since 2007 and has long understood the power of dollarization. The company currently charges in USD while incurring expenses in pesos so that if dollarization comes to fruition, the company would be positioned to realize a potential hundreds of thousands per year in revenue increase. The global luxury market is witnessing growth in light of a resurgence of social interactions and travel. The global luxury market is expected to reach $1.6 trillion in 2023, witnessing 8-10% growth over 2022. Despite macroeconomic challenges, the luxury market has shown resilience, and companies like Gaucho Group Holdings seem to be gearing up for growth. Scott Mathis, Chairman and CEO of Gaucho Holdings, shared, "In the immediate future, spanning about 6 to 8 months, we anticipate a substantial benefit from our USD rates against our labor costs in ARS, which represent a significant portion of our expenses. However, looking ahead to the next 10 to 12 months, we expect these advantages might reduce or possibly even disappear as labor unions in Argentina are likely to seek wage increases in response to economic changes. Despite these challenges, the first 8 months should witness a positive economic impact due to President Milei's pivotal reforms. The year 2024 is shaping up to be challenging, yet it presents opportunities, particularly in the real estate sector, which is poised to become a key driver of economic activity. Additionally, the banking sector's role in offering reasonable lending rates will be crucial during this period. We are committed to playing a significant role in this dynamic and evolving economic landscape, contributing to and thriving amidst these transformative changes." Gaucho Holdings emphasizes a critical aspect of the potential benefits of dollarization in Argentina, particularly in the realm of banking and real estate financing. A significant shift would occur if Argentine banks transitioned from dealing predominantly in pesos to using U.S. dollars. This change could pave the way for the reintroduction of traditional lending practices, including mortgages, which are currently almost non-existent in the country. In Argentina's current economic landscape, real estate transactions are predominantly cash-based. This is a concept that often seems foreign to Americans and Europeans, who are accustomed to financing such purchases through mortgages. Gaucho Holdings posits that allowing banks to offer lending in U.S. dollars could revolutionize the Argentine real estate market. It would not only provide a more accessible path for property acquisition but also potentially lead to a stabilization of the currency. The implications of this shift could be profound. By facilitating easier access to property ownership through bank lending, there could be a significant increase in real estate values. Gaucho Holdings suggests that the impact on the real estate market could be stratospheric, marking a transformative change in how properties are bought and sold in Argentina. Gaucho Holdings has emerged as a prominent player in the Argentine real estate market due to its strategic entry, well-established operations and diverse portfolio. Backed by a highly experienced management team, the company possesses a deep understanding of the market dynamics. With a focused mission to identify and cultivate opportunities in the undervalued luxury real estate sector of Argentina, Gaucho Holdings stands at the cusp of potential success amidst the recent political and socioeconomic changes in the country. If Milei can make good on his promise of dollarization, Gaucho Holdings is confident that profit will follow. Featured photo by Angelica Reyes on Unsplash Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 16, 2024 08:30 AM Eastern Standard Time

Image
Article thumbnail News Release

NASA, The US Navy And The US Army Are All Partners Of This Cutting-Edge Company – Laser Photonics Corporation (NASDAQ: LASE)

Benzinga

By Faith Ashmore, Benzinga Laser Photonics Corporation (NASDAQ: LASE) (“LPC”) is a leading global industrial developer of CleanTech laser systems for laser cleaning and other material applications. The company is best known for its specialization in integrated laser blasting solutions for corrosion control, rust removal, de-coating, pre- and post-welding, laser cleaning and surface conditioning which address the needs of a wide variety of industries. In order to maintain its position and drive growth, the company has implemented strategic plans that could position it at the forefront of technological advancements and trends in its industry. One key initiative is the enhancement of its AI and Internet of Things (IoT) capabilities. By integrating artificial intelligence and IoT technologies into its laser technology, LPC is able to offer cutting-edge solutions that improve the customer experience and aim to stay ahead of technological advancements. The company also offers on-site customer support and training with AI and IoT integration, further distinguishing itself from competitors. The global blasting market is projected to grow to $12 billion by 2025, and as more industries rely on laser technology, LPC may benefit from rising demand. The company has developed strategic partnerships with large distributors to expand its global sales network. By doing so, the company is ensuring that its innovative laser technology reaches a broader audience and remains accessible to industries globally. The success of its approach is evidenced by the fact that the company has worked with world-renowned companies and institutions like NASA, the U.S. Navy, the U.S. Army, Caterpillar Inc. (NYSE: CAT) and General Electric Co. (NYSE: GE), to name a few. LPC has also made it a priority to vertically integrate through key acquisitions. By acquiring or merging with suppliers or distributors, it reduces reliance on other businesses and exerts greater control over the quality, cost and availability of inputs or outputs. This enables LPC to optimize its supply chain operations and reduce costs associated with procurement, management, and distribution. Environmental stewardship is another LPC priority. The company is committed to delivering eco-friendly and sustainable solutions that help industries worldwide reduce their ecological footprint. LPC reports that its CleanTech technology uses no harmful chemicals or substances while achieving fast and accurate cleaning results, and its advanced productivity and safety features secure its reputation as a safer, more efficient option while ensuring operators are protected from the hazards of traditional systems. Companies that adhere to or exceed environmental regulatory requirements position themselves better in their markets as the world acts to combat climate change. In the long term, LPC is focused on expanding its Customer Experience Center (CEC) to provide a state-of-the-art facility for presenting and demonstrating its technology. The CEC showcases LPC’s capabilities to customers globally and facilitates customized solution collaborations on a global scale. The company continuously expands its product line with cutting-edge solutions such as MARLIN, DefenseTech and SaberTech demonstrating its commitment to meeting the evolving needs of industries across the globe. LPC’s robust research and development team is intensifying its efforts in developing Class I systems to maintain its competitive edge and meet the growing demand driven by increased regulations and restrictions. By maintaining a leading-edge presence in a range of industries, LPC seems to have earned its position as a trusted and safety-focused partner, offering state-of-the-art solutions that meet customer needs worldwide. Featured photo by SpaceX on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

February 16, 2024 08:25 AM Eastern Standard Time

Image
Article thumbnail News Release

Kadimastem advances towards Nasdaq: Company Signs a Memorandum of Understanding to Merge with a Company traded on the Nasdaq

Kadimastem

Kadimastem Ltd. (TASE: KDST), a leading cell therapy company in the clinical development stages of breakthrough products for the treatment of ALS and diabetes, announces that the company has signed a non-binding agreement in principle (“MOU”) for a merger with a public company traded on the NASDAQ. pursuant to the MOU Kadimastem shareholders are expected to hold 88% of the shares of the combined company post -merger upon which Kadimastem will no longer be trading on the Tel Aviv Stock Exchange. The MOU is in line with the company's strategic plan, to approach the target markets of its field of activity and the US capital markets. As part of the terms of the MOU, Kadimastem undertook to have approximately $5 million in funds, including capital raised simultaneously with the completion of the transaction and the commencement of trading from existing shareholders and additional investors. Ronen Twito, Executive Chairman of the Board said, "Listing Kadimastem on the NASDAQ is an important and necessary goal for Kadimastem’s development and its progress to the company's target markets in the U.S., as we have stated in the past. The MOU is an important step in that direction. It follows the Company's report of receipt of FDA approval for a Phase IIa multi-site clinical trial in the US for the treatment of ALS, and the joint development agreement signed with iTolerance Inc., a Florida based company with a product in the field of diabetes which we recently reported to have a successful joint INTERCT meeting with the FDA.” We believe that the exposure to the U.S. capital markets will assist Kadimastem in the development of the company's clinical assets and preparations for the planned multi-site clinical trial for the US, and as a result will create value for the company's shareholders." About Kadimastem Kadimastem is a clinical stage cell therapy company, developing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the company's lead product, is an astrocyte cell therapy in clinical development for the treatment for ALS and in pre-clinical studies for other neurodegenerative indications. IsletRx is the company's treatment for diabetes. IsletRx is comprised of functional pancreatic islet cells producing and releasing insulin and glucagon, intended to treat and potentially cure patients with insulin-dependent diabetes. Kadimastem was founded by Professor Michel Revel, CSO of the company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). Social Media: LinkedIn, Twitter, Facebook Kadimastem (TASE:KDST) is a clinical stage biotechnology company, with a unique platform for cell therapy that enables the production of off-the-shelf cell-based products for the treatment of unmet medical needs. Kadimastem was founded in 2009 based on patent protected technology that was developed at Prof. Michel Revel’s laboratory at the Weizmann Institute of Science. Forward Looking Statement This document may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under the Company's control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the Company's activity, as well as developments in the general environment and external factors affecting the Company's activity. The Company's results and achievements in the future may differ materially from any presented herein and the Company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This document does not constitute a proposal to purchase the Company's securities or an invitation to receive such offers. Investment in securities in general and in the Company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. Contact Details Kadimastem Ltd. Asaf Shiloni +972 73-797-1613 s.bazak@kadimastem.com Company Website https://www.kadimastem.com/

February 16, 2024 07:00 AM Eastern Standard Time

Image
Article thumbnail News Release

RapidClaims uses AI to help US healthcare providers address $250b in denied claims

RapidClaims

Healthcare organizations are turning to automation with “revenue cycle management” to protect operating margins and the increasing claim denials from the payors. Every year, close to $265B in claims made by US healthcare organizations are denied because of the way claims are coded on payor documentation and delayed submissions are two chief reasons for the denials. Coding errors account for over 40% of claim denials, while untimely submissions contribute to 35% of denials; eligibility and prior authorization being some of the other aspects playing a significant role. Addressing this pain point, RapidClaims has today emerged from stealth with a $3.1 million funding round to tackle the claims denial problem head-on with its medical coding automation module. The seed round was led by Together Fund, a $250 million global SaaS fund, with participation from Better Capital, Neon Fund, Peercheque, DeVC with angels and advisors coming from prominent US healthcare organizations including Oscar Benavidez (Executive Director, Mass General), Ankit Jain (Founder & CEO of Infinitus), and Sachin Jain (President & CEO of Scan Health) among others. RapidClaims is led by Dushyant Mishra (CEO), Jot Sarup Sahni (CPTO), and Abhinay Vyas (CDO), each bringing a nuanced understanding of healthcare, data science, and scaling tech products. The idea for RapidClaims originated in 2018 during Dushyant Mishra’s tenure at Abbott Healthcare when he observed the challenges faced by hospitals while interacting with multiple hospital owners and physicians. Since then, he has closely monitored the space, which gained significant momentum in 2022 as two key trends emerged: an increase in claim denial rates across the US and the effective demonstration of large language models (LLMs) as a solution to these challenges. RapidClaims recognizes the diverse challenges inherent in revenue cycle management. With a strategic focus on tackling medical coding initially, the company aims to simplify the rising complexity of coding processes and leverage the potential for AI to drive efficiencies over time. In recent years, coding complexity has surged significantly with diagnosis codes like ICD codes rising from 19,000 (ICD 9) to nearly 120,000 (ICD 11). Adherence to guidelines is becoming increasingly challenging due to rapid changes encompassing NCCI edits, NCD/LCD guidelines, Medicare policies, payor rule sets, among others. RapidClaims has achieved success with six pilots within two months of its beta product launch in June 2023 and is poised to enhance product robustness even further with an additional five pilots already in the pipeline. Dushyant Mishra, Founder & CEO of RapidClaims commented: "We are just beginning to witness tangible benefits in terms of cost savings, speed, and revenue enhancement through AI utilization. While automation is pivotal, we recognize the indispensable role of coders with their nuanced understanding of intricate rules and edge cases. This is the driving force behind our significant investment in the RapidAssist product, which has the transformative potential to elevate medical coding operations for coder-managing teams." AI holds immense potential for introducing exceptional efficiencies into this domain. Beyond identifying the right code, AI's current state allows for precise context interpretation, adding a layer of sophistication to the coding process. RapidClaims has unveiled three multi-specialty products aimed at alleviating coding administrative overload: RapidCode: Fully autonomous medical coding, streamlining the process with end-to-end automation. RapidAssist: A tailored tool for medical coders designed to improve productivity by auditing charts and identifying documentation gaps, which includes a query builder and rule-set engine. RapidRisk: Advanced AI for risk-adjusted coding that calculates HCC and RAF scores while pinpointing opportunities for documentation improvement based on a comprehensive rule set developed in collaboration with prominent CDI leaders. More healthcare organizations are recognizing the need for revenue cycle automation to overcome workforce challenges, handle increasing claim volumes, mitigate revenue losses, and navigate the complexities of healthcare administration. This urgency is further fueled by the rise in claim denials from payors, which puts significant pressure on healthcare providers and exacerbates the already high administrative costs. A recent study conducted by Bain & Company and KLAS reveals that 80% of U.S. healthcare providers are increasing their investment in IT and software, with a specific focus on prioritizing AI technologies. Revenue cycle transformation and automation are the top areas of focus for healthcare executives. Manav Garg, Co-founder of Together Fund added: "We are thrilled about the transformative potential of AI in optimizing administrative processes within the revenue cycle. We are confident that the RapidClaims team embodies the perfect blend of expertise, showcasing an in-depth understanding of the complexities within the U.S. healthcare system coupled with exceptional proficiency in artificial intelligence." About RapidClaims RapidClaims is automating medical coding to help health organizations reduce claim denials from payors. About Together Fund Together Fund is an enterprise software-focused, operator-led fund started by Girish Mathrubootham (Founder, Freshworks ), Manav Garg (Founder, Eka ) and Shubham Gupta (ex Matrix Partners). Together invests in Seed and Series A opportunities across AI, Devtools, Cloud Infra, Security, Horizontal & Vertical SaaS applications. With a “for-founders, by-founders” DNA, Together is joined by 150+ global founders & operators in this endeavor to help build global products. Contact Details RapidClaims Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.rapidclaims.ai/

February 16, 2024 06:00 AM Eastern Standard Time

Image
1 ... 239240241242243 ... 3587